戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ssay and 6.1 log10 copies/mL with polymerase chain reaction).
2 n each cell using droplet digital polymerase chain reaction.
3 ing Western blot and quantitative polymerase chain reaction.
4  examination, and droplet digital polymerase chain reaction.
5 ollected and tested for RSV using polymerase chain reaction.
6 everse-transcription quantitative polymerase chain reaction.
7  YM1) were evaluated by real time polymerase chain reaction.
8 nsitive allele-specific real-time polymerase chain reaction.
9  were amplified by ultrasensitive polymerase chain reaction.
10 emia was tracked via quantitative polymerase chain reaction.
11 nalyzed by quantitative real-time polymerase chain reaction.
12 ochemistry, western blotting, and polymerase chain reaction.
13 everse transcription quantitative polymerase chain reaction.
14 sites were serotyped by real-time polymerase chain reaction.
15 A were quantified by quantitative polymerase chain reaction.
16 measured by reverse transcription-polymerase chain reaction.
17  VP6 semi-quantitative, real-time polymerase chain reaction.
18 ver were assessed by quantitative polymerase chain reaction.
19 s were tested for influenza using polymerase chain reaction.
20 general primer GP5+/GP6+-mediated polymerase chain reaction.
21 stochemistry, flow cytometry, and polymerase chain reaction.
22 ry, immunoblots, and quantitative polymerase chain reaction.
23 encing, or real-time quantitative polymerase chain reaction.
24 g real-time reverse transcriptase-polymerase chain reaction.
25 ed in parasitemia by quantitative polymerase chain reaction.
26 lood smear (TBS) and quantitative polymerase chain reaction.
27 bovis BCG, as tested by real-time polymerase chain reaction.
28 Cases were confirmed by real-time polymerase chain reaction.
29 valuated by reverse transcriptase-polymerase chain reaction.
30 us those of reverse transcriptase polymerase chain reaction.
31 nalyzed by quantitative real-time polymerase chain reaction.
32  were visualized in situ using hybridization chain reaction.
33 COVID-19 by reverse-transcriptase polymerase chain reaction.
34 essed by culture and quantitative polymerase chain reaction.
35 everse-transcription quantitative polymerase chain reaction.
36 uantitative reverse-transcription polymerase chain reaction.
37  surface plasmon resonance and hybridization chain reaction.
38 y photo-induced electron transfer polymerase chain reaction.
39 dia (Pi) was done by quantitative polymerase chain reaction.
40 r influenza illness, confirmed by polymerase chain reaction.
41 everse transcription quantitative polymerase chain reaction.
42 f peroxy-hydroperoxide-mediated free-radical chain reactions.
43 tes in read counts resulting from polymerase chain reaction, a major source of noise.
44 everse transcription quantitative polymerase chain reaction, alone or in pools of different sizes (2-
45  purity for reverse transcription polymerase chain reaction amplification.
46 e performed reverse-transcription polymerase chain reaction analyses of 166 samples and immunohistoch
47                                   Polymerase chain reaction analyses of cardiac tissues have detected
48                      quantitative polymerase chain reaction analyses of representative genes validate
49 ing Western blot and quantitative polymerase chain reaction analyses.
50 atal tissues was verified by ChIP-polymerase chain reaction analyses.
51 try, transcriptome, and real-time polymerase chain reaction analyses.
52 uantitative reverse-transcriptase polymerase chain reaction analysis of 6 scleromyxedema skin samples
53 uantitative reverse transcription polymerase chain reaction analysis were measured in an independent
54  gondii coinfection documented by polymerase chain reaction analysis.
55 sed by taxa-specific quantitative polymerase chain reaction and 16S ribosomal RNA metagenomic sequenc
56  persons who infected mosquitoes, polymerase chain reaction and amplicon deep sequencing were used to
57 y real-time reverse transcription polymerase chain reaction and analyzed in relation to preinfection
58 antified by reverse-transcription polymerase chain reaction and area under the curve titers were dete
59 uantitative reverse-transcription polymerase chain reaction and evaluated the prognostic impact of NP
60  for PeV by reverse-transcription polymerase chain reaction and genotypes determined by subgenomic se
61 tro, using quantitative real-time polymerase chain reaction and immunoblotting.
62 ting these variants (quantitative polymerase chain reaction and NanoString).
63 , xMAP, and reverse-transcription polymerase chain reaction and organoids were generated.
64 S-CoV-2 via reverse-transcription polymerase chain reaction and performed symptom assessments.
65 everse transcription quantitative polymerase chain reaction and protein expression assessed with West
66 A in GF was analyzed by real-time polymerase chain reaction and protein expression visualized by immu
67 nt MAPREC (mutational analysis by polymerase chain reaction and restriction enzyme cleavage) assay fo
68 uantitative reverse transcription polymerase chain reaction and RNAscope) of small intestinal organoi
69                                   Polymerase chain reaction and Sanger sequencing therefore remain wi
70  with the introduction of digital polymerase chain reaction and single-cell sequencing.
71 mparable to standard quantitative polymerase chain reaction and the assays were within the limits of
72 erties were analyzed by real-time polymerase chain reaction and then analyzed for the percentage of e
73 poptotic assays, and quantitative polymerase chain reaction and Western blot analyses, were performed
74 uantitative reverse transcriptase polymerase chain reaction and Western blot showed a marked reductio
75 everse-transcription quantitative polymerase chain reaction) and had >=4-fold rise in serum-neutraliz
76 alyzed by histology, quantitative polymerase chain reaction, and 16S ribosomal RNA gene sequencing; l
77 , immunohistochemistry, real-time polymerase chain reaction, and enzyme-linked immunosorbent assay.
78 mistry, immunoblotting, real-time polymerase chain reaction, and flow cytometry.
79 y immunohistochemistry, real-time polymerase chain reaction, and flow cytometry.
80 munoblots, quantitative real-time polymerase chain reaction, and functional assays monitoring apoptos
81 ules was measured by quantitative polymerase chain reaction, and GCs and T follicular helper were ass
82 ochemistry, reverse-transcriptase polymerase chain reaction, and genotyping.
83 l swab specimens were assessed by polymerase chain reaction, and histopathological analysis and viral
84 immunoprecipitation, quantitative polymerase chain reaction, and immunoblot assays.
85 ays and by immunoblots, real-time polymerase chain reaction, and liquid chromatography-mass spectrome
86 oblotting, real-time quantitative polymerase chain reaction, and the Seahorse live-cell metabolic ass
87 confocal microscopy, quantitative polymerase chain reaction, and Western blot.
88 mmunohistochemistry, quantitative polymerase chain reaction, and Western blot.
89 amplification methods, such as hybridization chain reaction, are valuable tools for mapping the spati
90 ion is the reverse transcription- polymerase chain reaction assay (rt-PCR).
91                 Using a real-time polymerase chain reaction assay and deep sequencing, we reveal the
92 lues from a reverse transcription-polymerase chain reaction assay applied to nasopharyngeal swab samp
93 ously developed RLEP quantitative polymerase chain reaction assay for M. leprae, were validated as cl
94  designed a reverse-transcription polymerase chain reaction assay that targets antisense ZIKV RNA (as
95                             A CMV polymerase chain reaction assay was developed and run twice per wee
96 a specific real-time quantitative polymerase chain reaction assay was developed.
97 analysis (SARS-CoV-2 on real-time polymerase chain reaction assay), with correlation of pathologic an
98 everse transcription-quantitative polymerase chain reaction assay, flow cytometry analysis, and Weste
99 onfirmed by reverse transcription-polymerase chain reaction assay.
100 VDNA using a multianalyte digital polymerase chain reaction assay.
101 t causes COVID-19) on qualitative polymerase-chain-reaction assay, who were admitted between 3/8-5/6/
102 t causes Covid-19) on qualitative polymerase-chain-reaction assay.
103 values from reverse-transcription polymerase chain reaction assays applied to nasopharyngeal swab spe
104 atory tract reverse transcriptase polymerase chain reaction assays, (b) severe COVID-19 infection def
105 established reverse-transcription polymerase chain reaction assays.
106 species-specific and clade-typing polymerase chain reaction assays.
107 years 10 and 11, as identified by polymerase-chain-reaction assays for PorA (encoding porin protein A
108 aluated by quantitative real-time polymerase chain reaction at the end of each incubation period.
109 s (96%) had reverse transcriptase polymerase chain reaction based COVID-19 testing before their proce
110   Real-time reverse transcriptase polymerase chain reaction-based assays performed in a laboratory on
111        ESBL-PE isolates underwent polymerase chain reaction-based detection of diarrheagenic Escheric
112 2 RNA by nasal swab and real-time polymerase chain reaction between March 21 and May 4, 2020, were in
113 lyzed by immunoblot, quantitative polymerase chain reaction, chromosome immunoprecipitation, cell inv
114 is based on clinical features and polymerase chain reaction confirmation who were treated at a tertia
115 rge dispositions of patients with polymerase chain reaction-confirmed coronavirus disease 2019 (COVID
116  initial symptoms at the onset of polymerase chain reaction-confirmed coronavirus disease 2019 (COVID
117 tients with reverse transcriptase polymerase chain reaction-confirmed COVID-19 and n=24 non-COVID-19
118 er 10 000 persons and 95% CIs for polymerase chain reaction-confirmed COVID-19 diagnosis, hospitaliza
119 h real-time reverse transcription polymerase chain reaction-confirmed COVID-19 from two large Dutch c
120 tients with reverse-transcription polymerase chain reaction-confirmed COVID-19 who were admitted to a
121 who died of reverse-transcription polymerase chain reaction-confirmed COVID-19.
122 2 rapid tests in 77 patients with polymerase chain reaction-confirmed severe acute respiratory syndro
123           We used droplet digital polymerase chain reaction (ddPCR) to demonstrate that human DNA lev
124 cells; validation by quantitative polymerase chain reaction demonstrated overexpression of both miRNA
125                      We genotyped polymerase chain reaction-detected parasites using deep sequencing
126 l and nonclassical), custom-built polymerase chain reaction devices, gas-phase analyte detection syst
127 ression was assessed by real-time polymerase chain reaction, DNA damage by confocal microscopy, cell
128                           Digital polymerase chain reaction (dPCR) is a mature technique that has ena
129  good agreement with quantitative polymerase chain reaction effect concentrations determined within t
130 uantitative reverse transcription polymerase chain reaction), ELISA, co-IP, immunostaining, knockdown
131 mia detected by weekly plasma CMV polymerase chain reaction for 100 days (n = 100) or valganciclovir,
132 uantitative reverse transcription polymerase chain reaction for markers of autophagy, DNA damage, cel
133  results of reverse-transcription polymerase chain reaction for severe acute respiratory syndrome cor
134                                   Polymerase chain reaction for severe acute respiratory syndrome cor
135                         Real-time polymarase chain reaction for YF virus collected on the seventh day
136 cytometry, quantitative real-time polymerase chain reaction, functional analysis, and RNA microarrays
137 uorescence quantitative real-time polymerase chain reaction, further confirmed by fluorescence in sit
138 luated for real-time quantitative polymerase chain reaction gene expression using the TaqMan Gene Exp
139 con H(1) for TR recognition, H(2) for hybrid chain reaction (HCR) and DNA-cholesterol for size contro
140 astable DNA hairpins using the hybridization chain reaction (HCR) is reported.
141 ve been developed based on the hybridization chain reaction (HCR).
142 pression microarray, quantitative polymerase chain reaction, immunoblot, and immunofluorescence analy
143  assay, immunoblotting, real-time polymerase chain reaction, immunohistochemistry, and Masson trichro
144 r KSHV DNA detection by real-time polymerase chain reaction in blood and by viral shedding in saliva,
145 antified by reverse-transcription polymerase chain reaction in fecal samples from a subset of patient
146 L was measured using quantitative polymerase chain reaction in leukocytes extracted from cord blood s
147 icipants with virus detectable by polymerase chain reaction in nasopharyngeal swab at day 3.
148 th laboratory-verified (real-time polymerase chain reaction) InfA were identified.
149        We confirm that a superoxide-mediated chain reaction, initiated by electrocatalytic oxygen red
150 s of norbixin might be a result of a radical chain reaction involving peroxyl and carbon-centered rad
151 (OH) addition to C=C bonds and propagated by chain reactions involving Criegee intermediates (CIs).
152 zation bested the conventional hybridization chain reaction laddering at both biomechanical stability
153 reverse-transcription, long-range polymerase chain reaction (LRPCR) assay for efficient genome amplif
154  Cell viability assays, real-time polymerase chain reaction, luciferase reporter assays, chromatin im
155 sion were assessed with real-time polymerase chain reaction (n=4-6/group) and Western blot (n=3-4/gro
156 maquine/chloroquine arm) remained polymerase chain reaction-negative.
157  rRNA sequencing and quantitative polymerase chain reaction of archaeal and bacterial nitrogen cyclin
158 MiSeq sequencing and quantitative polymerase chain reaction of denitrification genes.
159 hological analysis; (c) real-time polymerase chain reaction of endothelial nitric oxide synthase (eNO
160 itive for SARS-CoV-2 infection by polymerase chain reaction of nasopharyngeal swab or serology.
161  by culture and/or real-time (RT) polymerase chain reaction (PCR) >30 days after symptom onset.
162 tions, using both microscopy- and polymerase chain reaction (PCR) -based methods, was performed month
163 ers (245 SSR) was validated using polymerase chain reaction (PCR) amplification, of which 167 primers
164 d rRNA in CSF were detected using polymerase chain reaction (PCR) and reverse transcriptase PCR.
165 CoV-2 diagnostic test modalities, polymerase chain reaction (PCR) and serology, over the disease cour
166    16S ribosomal-ribonucleic acid polymerase chain reaction (PCR) and targeted PCR aid microbiologica
167 uantitative reverse transcriptase polymerase chain reaction (PCR) and/or IgM Zika MAC-ELISA.
168           The evaluation of miRNA polymerase chain reaction (PCR) arrays indicated that the expressio
169                       Multiplexed polymerase chain reaction (PCR) assays increase the detection of di
170                             While polymerase chain reaction (PCR) detection corresponded well to ZsG
171 ngland for characterization using polymerase chain reaction (PCR) detection of GES, pulsed-field gel
172 sitive for the causative virus by polymerase chain reaction (PCR) even after clinical recovery, there
173             A cerebrospinal fluid polymerase chain reaction (PCR) for herpes simplex virus (HSV) and
174  quantitative multiplex real-time polymerase chain reaction (PCR) for Pneumocystis jirovecii and comm
175 ng were used to design a specific polymerase chain reaction (PCR) for screening unsuspected cases inf
176                               The polymerase chain reaction (PCR) has been the gold standard molecula
177 imes higher to that obtained with polymerase chain reaction (PCR) in current general use.
178 on of SARS-CoV-2 RNA by real-time polymerase chain reaction (PCR) in respiratory samples collected fr
179 SARS-CoV-2 infection confirmed by polymerase chain reaction (PCR) in seropositive and seronegative he
180  deletions by multiplex real-time polymerase chain reaction (PCR) in the fibroblast cultures.
181                                   Polymerase chain reaction (PCR) is the preferred diagnostic but is
182  to perform reverse transcription polymerase chain reaction (PCR) is the primary method currently use
183 nated kidneys was performed using polymerase chain reaction (PCR) panels.
184  they had a positive C. difficile polymerase chain reaction (PCR) performed on an unformed stool and
185 poridian parasites using a nested polymerase chain reaction (PCR) protocol that targets the parasite
186  on procalcitonin and respiratory polymerase chain reaction (PCR) results could help reduce inappropr
187 SARS-CoV-2) infection detected on polymerase chain reaction (PCR) screening of a large homeless shelt
188             Recent ultrasensitive polymerase chain reaction (PCR) technology now allows absolute quan
189 ogy study characterizes trends in polymerase chain reaction (PCR) test positivity for severe acute re
190 y documents results of SARS-CoV-2 polymerase chain reaction (PCR) testing of environmental surfaces a
191                                   Polymerase chain reaction (PCR) testing of maternal, placental, and
192  acid-based reverse transcription polymerase chain reaction (PCR) testing.
193 ily (days 1 to 14) for SARS-CoV-2 polymerase chain reaction (PCR) testing.
194 ed Raman spectroscopy (SERS), and polymerase chain reaction (PCR) with a statistical tool to identify
195  analyzing point mutations, e.g., polymerase chain reaction (PCR), are based on differences in therma
196 ignificant reaction inhibition of polymerase chain reaction (PCR), loop-mediated isothermal amplifica
197 r at 1 month by antibody testing, polymerase chain reaction (PCR), or hospital diagnosis.
198 ary outcome was the proportion of polymerase chain reaction (PCR)-adjusted adequate clinical and para
199  contribution of a combination of polymerase chain reaction (PCR)-based tests to culture methods, in
200  first 18 patients diagnosed with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection at 4
201 for the rs4680 SNP using realtime polymerase chain reaction (PCR).
202 are then returned to the user for polymerase chain reaction (PCR).
203  of 16S ribosomal RNA gene (rRNA) polymerase chain reaction (PCR)/sequencing of SF and compare it wit
204      As on date, the traditional polymerized chain reactions (PCR), lateral flow devices (LFID) and e
205 tomatic contacts of patients with polymerase-chain-reaction (PCR)-confirmed Covid-19 in Catalonia, Sp
206 d and tissue culture, plus tissue polymerase chain reaction [PCR] for Salmonella Typhi).
207                                   Polymerase chain reaction-positive (+) measles cases notified to Vi
208  adult hospitalized patients with polymerase chain reaction positivity for severe acute respiratory s
209              Through quantitative polymerase chain reaction (qPCR) analysis, we found that our inerti
210 his paper, multiplex quantitative polymerase chain reaction (qPCR) assay using TaqMan probe was devel
211            Quantitative real time polymerase chain reaction (qPCR) data are normalised using endogeno
212                      Quantitative polymerase chain reaction (qPCR) is the technique of choice for qua
213 ere quantified using quantitative polymerase chain reaction (qPCR) of the nifH (marker gene used to i
214                      Quantitative polymerase chain reaction (qPCR) was performed for specific pathoge
215       As a reference quantitative polymerase chain reaction (qPCR) was performed.
216 e analyzed by ELISA, quantitative polymerase chain reaction (qPCR), and immunohistochemistry.
217 med by microscopy or quantitative polymerase chain reaction (qPCR), were included in the study.
218 gnostic testing with quantitative polymerase chain reaction (qPCR).
219 icular disease using quantitative polymerase chain reaction (qPCR).
220 RS-CoV-2 by means of quantitative polymerase-chain-reaction (qPCR) assay of nares swab specimens obta
221 after diagnosis by a quantitative polymerase-chain-reaction (qPCR) assay.
222 ated using quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC).
223 uantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) and western blot analysis perfo
224 nfirmed by quantitative real time-polymerase chain reaction (QRT-PCR) as a standard method in adulter
225            Quantitative real time polymerase chain reaction (qRT-PCR) was used to analyse neuronal-as
226 uantitative reverse-transcription polymerase chain reaction (qRT-PCR).
227 sues were processed for real-time polymerase chain reaction (real-time PCR) assessment of markers of
228 y 2013-May 2017 with positive RSV polymerase chain reaction respiratory specimens was performed.
229 utoxidation is an autocatalytic free-radical chain reaction responsible for the oxidative destruction
230 evalence of reverse-transcriptase polymerase chain reaction results positive for severe acute respira
231 tients with reverse transcription polymerase chain reaction results positive for severe acute respira
232 uantitative reverse transcriptase polymerase chain reaction, RNAscope) content.
233 n real-time reverse-transcriptase-polymerase-chain-reaction (rRT-PCR) assay.
234             Reverse transcription-polymerase chain reaction (RT-PCR) analysis or serological testing
235 2) based on reverse transcriptase polymerase chain reaction (RT-PCR) are being used to rule out infec
236 ods such as reverse transcription polymerase chain reaction (RT-PCR) are the gold standard, during th
237 ronavirus 2 reverse-transcription polymerase chain reaction (RT-PCR) assay and a clinical reference s
238             Reverse transcription-polymerase chain reaction (RT-PCR) data showed that both M2 and M13
239 , real time reverse transcriptase polymerase chain reaction (RT-PCR) examination of abdominal fluid w
240             Reverse-transcription polymerase chain reaction (RT-PCR) has become the primary method to
241  viruses by reverse-transcription polymerase chain reaction (RT-PCR) in Australia, Canada, Israel, an
242 atients had reverse transcription polymerase chain reaction (RT-PCR) results obtained before CT scan
243 us-specific reverse transcriptase polymerase chain reaction (RT-PCR) test is routinely used.
244  SARS-CoV-2 reverse transcriptase polymerase chain reaction (RT-PCR) test result and who were tested
245 irus 2 is a reverse transcription polymerase chain reaction (RT-PCR) test, but chest CT may play a co
246             Reverse-transcription polymerase chain reaction (RT-PCR) tests are accurate but costly, w
247 and in whom reverse transcription-polymerase chain reaction (RT-PCR) was performed (mean, 62 years +/
248 2) based on reverse-transcriptase polymerase chain reaction (RT-PCR), antibody testing, or exposure t
249 traditional reverse-transcription polymerase chain reaction (RT-PCR), novel quantitative RT-PCR prime
250 d method of reverse transcription-polymerase chain reaction (RT-PCR), particularly after the second w
251 employed is reverse transcription polymerase chain reaction (RT-PCR), which can have good sensitivity
252 h real-time reverse-transcription polymerase chain reaction (RT-PCR)-confirmed COVID-19 in each of th
253 ta from 170 reverse transcriptase-polymerase chain reaction (RT-PCR)-confirmed influenza virus A(H1N1
254 people with reverse-transcription polymerase chain reaction (RT-PCR)-confirmed SARS-CoV-2 infection,
255 d real-time reverse transcription polymerase chain reaction (RT-PCR).
256 nfluenza by reverse-transcriptase polymerase chain reaction (RT-PCR).
257 l genes via reverse transcriptase polymerase chain reaction (RT-PCR).
258 onfirmed by reverse transcription polymerase chain reaction (RT-PCR).
259 uantitative reverse transcription-polymerase chain reaction (RT-qPCR) after 3, 6, or 24 hours of IL-1
260 nscription quantitative real-time polymerase chain reaction (RT-qPCR) is widely used for mRNA quantif
261 everse transcription-quantitative polymerase chain reaction (RT-qPCR) to detect the purified SARS-CoV
262 uantitative reverse transcription polymerase chain reaction (RT-qPCR)) and infectivity (TCID(50)).
263 everse transcriptase-quantitative polymerase chain reaction (RT-qPCR), 14 of which resulted in genome
264 reverse transcriptase - real-time polymerase chain reaction (RT-qPCR).
265 everse transcription quantitative polymerase chain reaction (RT-qPCR).
266 uantitative reverse transcription-polymerase chain reaction (RT-qPCR).
267 by means of reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay.
268 th positive reverse transcription polymerase chain reaction [RT-PCR] results, 231 with negative RT-PC
269           Furthermore, based on a polymerase chain reaction screening for core BL genes, 93% of child
270  patients, we performed real-time polymerase chain reaction screening for the new variant.
271  utility of universal broad-range polymerase chain reaction sequencing for pathogen detection.
272     Validation using quantitative polymerase chain reaction showed significant upregulation of miR-17
273 nscripts detected by quantitative polymerase chain reaction (sws1, sws2, rh2.3, rh2.4, lws, and rh1)
274 hod and a SYBR Green quantitative polymerase chain reaction (SyG-qPCR) assay were combined to generat
275  a positive reverse transcription-polymerase chain reaction test for SARS-CoV-2.
276 S-CoV-2 via reverse transcription polymerase chain reaction testing, although false-negative test res
277 e result on reverse-transcription polymerase chain reaction testing, and no oligoclonal banding.
278 nfection, determined by viral RNA polymerase chain reaction testing.
279 2-2015) underwent influenza virus polymerase chain reaction testing.
280        Both reverse transcriptase polymerase chain reaction tests and rapid nucleic acid-based tests
281 describes the point prevalence of polymerase chain reaction tests positive for severe acute respirato
282           Results from SARS-CoV-2 polymerase chain reaction tests were positive in 15 of 58 patients
283 obust than reversed transcription polymerase chain reaction (the current standard), but its limit of
284 S rRNA gene and used quantitative polymerase chain reaction to detect Streptococcus mitis, Streptococ
285 rmation Study were analyzed using polymerase chain reaction to determine the influenza virus (sub-)ty
286 used patch clamp and quantitative polymerase chain reaction to measure electrophysiological features
287  or expensive and time-consuming (polymerase chain reaction) to perform.
288 istry, and quantitative real-time polymerase chain reaction; tumors were analyzed by mass cytometry u
289 ronavirus 2 reverse transcription polymerase chain reaction was negative in nasopharyngeal, stool, an
290 otein in media, whereas real-time polymerase chain reaction was performed to evaluate the mRNA levels
291 amplification, magnetics) digital polymerase chain reaction was seen in 10/14 patients (71.4%) achiev
292 urface-tethered probes and the hybridization chain reaction was used to amplify the detection signal
293            Using semiquantitative polymerase chain reaction, we showed that Tmprss9 is expressed in v
294 n real-time reverse transcriptase polymerase chain reaction were identified.
295 l examination and droplet digital polymerase chain reaction were negative for viral presence.
296               Multiplex real-time polymerase chain reactions were performed, detecting several STIs a
297 g real-time reverse-transcription polymerase chain reaction, Western blotting, immunohistochemistry,
298 ible to the noxious lipid peroxidation (LPO) chain reaction, which is a common feature of various neu
299 itive RNAemia measured by digital polymerase chain reaction who were treated with 4 units of COVID-19
300 d using Western blot and specific polymerase chain reaction with sequencing on a different valve samp

 
Page Top